Eli Lilly Agrees To Pay $15M To Settle Alaska Medicaid Lawsuit Filed Over Zyprexa Allegations
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Litigation / Medical Malpractice; Schizophrenia
Article Date: 27 Mar 2008 - 7:00 PDT
Eli Lilly has agreed to pay $15 million to settle a lawsuit filed by the state of Alaska over allegations that the company concealed data about the side effects of Zyprexa, a schizophrenia and bipolar disorder medication, and cost the state Medicaid program millions of dollars because of an increased incidence of diabetes among beneficiaries, the Indianapolis Star reports (Spalding, Indianapolis Star, 3/26). According to the lawsuit, filed in 2006, Zyprexa led to a number of health problems -- such as weight gain, hypertension and diabetes -- in Alaska Medicaid beneficiaries (AP/Miami Herald, 3/26). The lawsuit sought $270 million in damages.
Under the settlement, which ended a trial that began on March 3, Lilly agreed to ensure that Alaska is "treated as favorably as any other state" in any future settlements of similar lawsuits (Indianapolis Star, 3/26). Lilly faces lawsuits filed by at least nine other states over allegations that the company illegally marketed Zyprexa for unapproved uses and concealed data on the side effects of the medication (Manzor, Wall Street Journal, 3/26). Lilly made no admission of wrongdoing in the settlement (AP/Miami Herald, 3/26).
Lilly general counsel Robert Armitage said that the company had a "strong defense" but decided to settle the lawsuit in the interests of all parties involved. He added, "Our decision to resolve this case does not change the fact that Zyprexa can continue to improve the lives of patients around the world who are suffering from schizophrenia and bipolar disorder" (Indianapolis Star, 3/26).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/101839.php>
APA
http://www.medicalnewstoday.com/releases/101839.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Zyprexa Diabetes Connection
posted by Daniel Haszard on 27 Mar 2008 at 7:26 am9+ more states still to deal.
The settlement with the feds could top $1 billion.
Eli Lilly has 'promised' a $1.2 billion personal injury settlement with individual claimants like myself who have NOT been paid yet.
Zyprexa remains on the market in the United States and more than 80 other countries.
About 30 state attorneys general have subpoenaed documents detailing Lilly's sales practices for Zyprexa as part of a civil investigation under state consumer protection laws.
I took Zyprexa for 4 years 1996-2000 (before the black box warning) at $250 a month co-pay. I got a shocking BG (blood sugar) of 500 in 2000.My doctors say it WAS the Zyprexa that caused it. I have NO diabetes in my family.
Moreover,I was given it off-label for PTSD.
Daniel Haszard http://www.zyprexa-victims.com
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




